The United Nations-backed Stop TB Partnership said J&J's new price of $130 and Lupin's price of $194 for a six-month course of the treatment represented a 55  and 33  price reduction, respectively. Lupin, and J&J will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and middle-income countries, a global anti-tuberculosis group said on Wednesday.
Lupin and J&J have reduced the price of bedaquiline, a tuberculosis drug, by 55% and 33%, respectively, for low- and middle-income countries.